🔎 Trials Near Me

Akèy › Lukemi miyoyid kwonik

Etid klinik pou Lukemi miyoyid kwonik ap rekrite nan Etazini

48 etid pou Lukemi miyoyid kwonik ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Ap rekriteEtid obsèvasyon
Laj 0 a 38 · Tout sèks · Mizajou Oct 1, 2026 · NCT06131801

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

Ap rekriteFaz 1/2
Laj 1 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT04925479

Study of Olverembatinib (HQP1351) in Patients With CML-CP

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06423911

Cord Blood Transplant in Adults With Blood Cancers

Ap rekriteFaz 2
Laj 21 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT05884333

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

Ap rekriteFaz 2
Laj 1 a 18 · Tout sèks · Mizajou Sep 2, 2026 · NCT07354074

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT05334069

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Ap rekriteFaz 1
1 Day – 21 Years · Tout sèks · Mizajou Aug 26, 2026 · NCT05857969

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

Ap rekriteFaz 1
Laj 18 a 80 · Tout sèks · Mizajou Aug 17, 2026 · NCT07302776

Allo HSCT Using RIC and PTCy for Hematological Diseases

Ap rekriteFaz 2
Jiska laj 75 · Tout sèks · Mizajou Jul 6, 2026 · NCT05805605

Asciminib Roll-over Study

Ap rekriteFaz 4
Laj 7 a 100 · Tout sèks · Mizajou Jul 6, 2026 · NCT04877522

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Registry of Older Patients With Cancer

Ap rekriteEtid obsèvasyon
Laj 65 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT01137825

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Ap rekriteFaz 2
Jiska laj 60 · Tout sèks · Mizajou Jun 25, 2026 · NCT03314974

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT07638007

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.